Evidence map›Paper›PMID 41133741›Full record

ArticleMicrobiology (Reading, England)2025

Dominance of non-

René Quezada, Manuel Kirchmayr, Melchor Arellano-Plaza, J Alejandro Morales, John P Morrissey, Anne Gschaedler

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

René QuezadaDepartment of Industrial Biotechnology, CIATEJ, 1227 Camino Arenero, El Bajío, Zapopan,Jalisco, 45019, Mexico.
Manuel KirchmayrDepartment of Industrial Biotechnology, CIATEJ, 1227 Camino Arenero, El Bajío, Zapopan,Jalisco, 45019, Mexico.
Melchor Arellano-PlazaDepartment of Industrial Biotechnology, CIATEJ, 1227 Camino Arenero, El Bajío, Zapopan,Jalisco, 45019, Mexico.
J Alejandro MoralesDepartment of Computer Science, CUCEI-UdeG, 1421 Marcelino García Barragán, Olímpica, Jalisco 44430, Mexico.
John P MorrisseySUSFERM Fermentation Science Centre, School of Microbiology, University College Cork, T12 K8AF, Cork, Ireland.
Anne GschaedlerDepartment of Industrial Biotechnology, CIATEJ, 1227 Camino Arenero, El Bajío, Zapopan,Jalisco, 45019, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mezcal is a spirit obtained from the fermentation and distillation of juices obtained from different agave species. It is one of the distilled beverages with great sociocultural value in different regions of Mexico, and in recent years, it has also gained great economic importance. It is known to present differences in its flavour, thanks to the richness of compounds incorporated within the spirit, which vary according to the agave species used, the microbial population present and the processes involved in its manufacture. This variety reflects the richness of local traditions and the craftsmanship behind its production. The main objective of the present work was to explore parameters that could impact fungal and bacterial diversity. The microbiome of bacteria and yeasts present in fermentations in the same distillery, in two different years and with three different agave species was investigated by metataxonomic analysis obtained from the sequencing of regions V3-V4 for bacteria and ITS1 for yeasts. The results showed that the dominant fungal genera in the fermentations correspond to non-

Indexed as

AgaveAlcoholic BeveragesYeastsBacteriaBiodiversityFermentationFood MicrobiologyMexicoMicrobiotaagaveLactobacillusmetataxonomicsmezcalnon-conventional yeast

Identifiers

PMID41133741
PMCPMC12551765

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.